Loading…
Boston Scientific Corporation is projected to rise to $58.66 by 2027, a +16% move from its current price of $50.46. BSX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $49.37 | $50.47 | $51.60 | +0.03% |
| May 30 | $48.94 | $50.49 | $52.08 | +0.05% |
| May 31 | $48.61 | $50.50 | $52.46 | +0.08% |
| Jun 1 | $48.34 | $50.51 | $52.78 | +0.10% |
| Jun 2 | $48.10 | $50.53 | $53.07 | +0.13% |
| Jun 3 | $47.89 | $50.54 | $53.34 | +0.15% |
| Jun 4 | $47.69 | $50.55 | $53.58 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $47.69 | $50.55 | $53.58 | +0.18% |
| Week 2 | $46.64 | $50.64 | $54.99 | +0.36% |
| Week 3 | $45.87 | $50.73 | $56.12 | +0.54% |
| Week 4 | $45.24 | $50.83 | $57.10 | +0.73% |
| Week 5 | $44.70 | $50.92 | $58.00 | +0.91% |
| Week 6 | $44.23 | $51.01 | $58.83 | +1.09% |
| Week 7 | $43.81 | $51.10 | $59.61 | +1.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Boston Scientific Corporation is a healthcare company that develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular, and offers devices to diagnose and treat a broad range of conditions—from gastrointestinal and urological issues to heart rhythm disorders and cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Its portfolio includes technologies such as WATCHMAN FLX, left atrial appendage closure devices, implantable cardiovascular monitors, and other diagnostic and therapeutic devices across its two segments. These offerings span a wide array of endoscopic, urological, neurological, and cardiac applications, reflecting a diverse medical device business with global reach.
Boston Scientific Corporation (BSX) trades at $50.46 with a market cap of $75B and is ranked 218 by market capitalization. The current price sits below key moving averages, signaling potential near-term softness versus longer-term benchmarks. The stock’s 30-day price range is $43.65 to $58.33, with a defined support at $50.46 and resistance at $65.69.
Technical momentum is described as NEUTRAL, with an RSI of 30 and annualized volatility of 40%. The 50-day simple moving average is $61.00 and the 200-day simple moving average is $85.76, indicating the price is trading under both moving averages at present.
Forecasts provide a multi-year view, showing a path from neutral in 2026 toward bullish growth in later years, with the average price rising from $50.46 in 2026 to $74.60 in 2030 and extending to $144.93 by 2040 and $228.02 by 2050, alongside substantial ROI improvements.
A major floor 20.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 30.2% above — a clean break opens room to run.
A major ceiling 85.9% above — clearing it would confirm fresh momentum.
Key BSX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BSX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $55.94 | Sell | $54.83 | Sell |
| MA 10 | $55.17 | Sell | $55.35 | Sell |
| MA 20 | $55.49 | Sell | $56.40 | Sell |
| MA 50 | $61.00 | Sell | $61.38 | Sell |
| MA 100 | $71.75 | Sell | $69.64 | Sell |
| MA 200 | $85.76 | Sell | $79.29 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.86 | Neutral |
| Stoch RSI (14) | 12.11 | Buy |
| CCI (20) | -194.10 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.32 | Buy |
| ROC (12) | -6.43 | Sell |
| Bollinger %B (20,2) | -0.13 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.51 | Sell |
| Awesome (5,34) | -2.40 | Sell |
| Ultimate (7,14,28) | 38.80 | Neutral |
| Momentum (10) | -3.64 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 56.16 | Sell |
| ADX (14) | 23.88 | Sell |
| ATR (14) | 1.47 | Info |
The near-term technical picture shows a stock trading at a price near support. The RSI is 30, which suggests neutral to mildly oversold conditions. The price remains below the SMA50 of $61.00 and well below the SMA200 of $85.76, highlighting a softer near-term bias.
The 30-day range is $43.65 to $58.33, and the current price of $50.46 sits between that range’s midpoint. With support at $50.46 and resistance at $65.69, momentum could shift if the price tests or breaks these levels, but near-term pressure remains a consideration given the undershoot relative to longer-term averages.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $50.46 | $50.46 | $62.51 | 0% | Neutral | |
| $47.40 | $58.66 | $76.35 | +16% | Neutral | |
| $54.82 | $69.31 | $92.93 | +37% | Bullish | |
| $54.21 | $69.77 | $95.77 | +38% | Bullish | |
| $57.06 | $74.60 | $104.47 | +48% | Bullish | |
| $58.45 | $77.52 | $110.48 | +54% | Bullish | |
| $58.19 | $78.21 | $113.25 | +55% | Bullish | |
| $64.19 | $87.36 | $128.34 | +73% | Bullish | |
| $71.58 | $98.57 | $146.74 | +95% | Bullish | |
| $77.08 | $107.34 | $161.80 | +113% | Bullish | |
| $98.93 | $144.93 | $230.20 | +187% | Bullish | |
| $142.91 | $228.02 | $391.30 | +352% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $50.46 | $50.46 | $59.03 | +0.00% |
| June 2026 | $43.47 | $50.84 | $60.71 | +0.75% |
| July 2026 | $43.88 | $51.66 | $62.37 | +1.62% |
| August 2026 | $42.76 | $50.62 | $61.62 | -2.03% |
| September 2026 | $41.70 | $49.58 | $60.77 | -2.05% |
| October 2026 | $42.17 | $50.33 | $62.08 | +1.51% |
| November 2026 | $42.38 | $50.76 | $62.95 | +0.86% |
| December 2026 | $41.73 | $50.15 | $62.51 | -1.21% |
Click any year to see its month-by-month BSX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BSX price prediction for 2026 points to an average of $50.46 (low $50.46, high $62.51) — a potential gain of 0% on today's $50.46. Price action looks broadly range-bound.
In 2027, BSX is projected to trade between $47.40 and $76.35, averaging $58.66 — a potential gain of +16% from today's $50.46. That is up +16% on the projected 2026 average. A consolidation phase looks the most probable path here.
Boston Scientific Corporation's 2028 outlook centres on $69.31, within a $54.82 to $92.93 range. That is up +18% on the projected 2027 average. That marks a +37% change versus current levels. Momentum favours further upside here.
By 2029, BSX could reach as high as $95.77, with a base case around $69.77 and support toward $54.21 — roughly +38% from $50.46. Buyers look set to stay in control over this stretch.
Expect BSX to range from $57.06 to $104.47 through 2030. The $74.60 average target implies a +48% move from current prices. That is up +7% on the projected 2029 average. Momentum favours further upside here.
The BSX price prediction for 2031 points to an average of $77.52 (low $58.45, high $110.48) — a potential gain of +54% on today's $50.46. Buyers look set to stay in control over this stretch.
In 2032, BSX is projected to trade between $58.19 and $113.25, averaging $78.21 — a potential gain of +55% from today's $50.46. That is up +1% on the projected 2031 average. Momentum favours further upside here.
Boston Scientific Corporation's 2033 outlook centres on $87.36, within a $64.19 to $128.34 range. That is up +12% on the projected 2032 average. That marks a +73% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, BSX could reach as high as $146.74, with a base case around $98.57 and support toward $71.58 — roughly +95% from $50.46. Momentum favours further upside here.
Expect BSX to range from $77.08 to $161.80 through 2035. The $107.34 average target implies a +113% move from current prices. That is up +9% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The BSX price prediction for 2040 points to an average of $144.93 (low $98.93, high $230.20) — a potential gain of +187% on today's $50.46. Momentum favours further upside here.
In 2050, BSX is projected to trade between $142.91 and $391.30, averaging $228.02 — a potential gain of +352% from today's $50.46. That is up +57% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in BSX today (≈ 19.817677 BSX) could be worth
$4,518.9
+$3,518.9 (+352%) by 2050 · US Dollar
Based on the average projected BSX price of $228.02 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BSXwould be worth at today's price.
$1,000 invested in BSX on May 27, 2025 (≈ 9.418857 BSX) would be worth
$475.28
-$524.72 (-52.5%) today · 0.48× · US Dollar
Based on a BSX entry price of $106.17 vs. today's $50.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $56.67 | $890.42 | -11.0% |
| 1 month ago | $59.95 | $841.7 | -15.8% |
| 3 months ago | $75.75 | $666.14 | -33.4% |
| 6 months ago | $101.58 | $496.75 | -50.3% |
| 1 year ago | $106.17 | $475.28 | -52.5% |
| All time (5.0y) ago | $42.93 | $1,175.4 | +17.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BSX forecast.
Our base-case forecast reaches $100.00 around 2035.
Implied market cap at $100.00: $148.64B
The year-by-year forecast shows a bullish arc from 2027 onward, with the avg price rising from $58.66 in 2027 to $74.60 in 2030 and continuing higher to $144.93 in 2040 and $228.02 in 2050. The corresponding ROIs move from 16.3% in 2027 to 47.9% in 2030, 187.2% in 2040, and 351.9% in 2050, indicating a strong long-run upside relative to today’s level.
2028 and 2029 show solid growth, with avg prices of $69.31 and $69.77 and ROIs of 37.4% and 38.3%, respectively. By 2031–2032, the averages reach $77.52 and $78.21, with ROIs of 53.6% and 55.0%. The forecast continues to trend higher through 2033 ($87.36 avg, 73.1% ROI) and 2034 ($98.57 avg, 95.3% ROI), signaling sustained bullish momentum.
The long-range outlook remains bullish, with 2040 projected at $144.93 average price and 187.2% ROI, and 2050 projected at $228.02 average price and 351.9% ROI. These figures imply meaningful upside potential should the trajectory hold, but they are estimates and not guarantees, with risks inherent in market and medical-device sector dynamics.
Tap a question to reveal the answer.
In 2030, the average price is projected to be $74.60, with a low of $57.06 and a high of $104.47, and an ROI of 47.9%, with bullish sentiment.
The forecast shows bullish sentiment from 2027 onward, with rising averages and ROI reaching 47.9% in 2030, 187.2% in 2040, and 351.9% in 2050, though these are estimates and not guarantees.
Yes. The forecast max prices reach $230.20 in 2040, indicating that reaching $200 is within the projected range for that year (2035 max $161.80, 2040 max $230.20).
The current price is $50.46.
The 30-day range is $43.65 to $58.33.
Boston Scientific Corporation Community Discussion
0Share your Boston Scientific Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.